Aurora Cannabis (ACB) Liabilities and Shareholders Equity (2018 - 2026)

Aurora Cannabis (ACB) has reported Liabilities and Shareholders Equity for 9 consecutive years, with $438.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 26.24% year-over-year to $438.3 million; the TTM figure through Mar 2026 stood at $2.1 billion (down 11.04% YoY), while the FY2026 annual figure was $438.3 million, down 28.54% from the prior year.
• Liabilities and Shareholders Equity eased to $438.3 million in Q1 2026 per ACB's latest filing, from $556.0 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $1.2 billion in Q1 2022 and bottomed at $438.3 million in Q1 2026.
• Historically, Liabilities and Shareholders Equity has averaged $673.2 million across 5 years, with a median of $612.2 million in 2024.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity plunged 61.75% — and 2024, when it advanced 2.84%.
• Aurora Cannabis' Liabilities and Shareholders Equity stood at $754.3 million in 2022, then declined by 20.42% to $600.2 million in 2023, then gained by 2.84% to $617.3 million in 2024, then declined by 9.93% to $556.0 million in 2025, then decreased by 21.16% to $438.3 million in 2026.
• Business Quant data shows ACB's Liabilities and Shareholders Equity at $438.3 million in Q1 2026, $556.0 million in Q4 2025, and $550.0 million in Q3 2025.